69 related articles for article (PubMed ID: 21873168)
1. Novel complementary peptides to target molecules.
Okada H; Imai M; Ono F; Okada A; Tada T; Mizue Y; Terao K; Okada N
Anticancer Res; 2011 Jul; 31(7):2511-6. PubMed ID: 21873168
[TBL] [Abstract][Full Text] [Related]
2. Antisense homology boxes in C5a receptor and C5a anaphylatoxin: a new method for identification of potentially active peptides.
Baranyi L; Campbell W; Okada H
J Immunol; 1996 Nov; 157(10):4591-601. PubMed ID: 8906838
[TBL] [Abstract][Full Text] [Related]
3. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway.
Xu H; Su Z; Wu J; Yang M; Penninger JM; Martin CM; Kvietys PR; Rui T
J Immunol; 2010 Feb; 184(3):1492-8. PubMed ID: 20028656
[TBL] [Abstract][Full Text] [Related]
4. [Advances in research of the roles of C5a-C5L2, high mobility group B1 and Toll like receptor 4 in sepsis].
Fang Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):155-7. PubMed ID: 25665619
[No Abstract] [Full Text] [Related]
5. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
Tang Y; Lv B; Wang H; Xiao X; Zuo X
Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic peptides against human anaphylatoxin C5a.
Kaneko Y; Okada N; Baranyi L; Azuma T; Okada H
Immunology; 1995 Sep; 86(1):149-54. PubMed ID: 7590876
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models.
Hagiwara S; Iwasaka H; Matsumoto S; Hasegawa A; Yasuda N; Noguchi T
Shock; 2010 Mar; 33(3):282-8. PubMed ID: 19536047
[TBL] [Abstract][Full Text] [Related]
8. Increased inhibitory capacity of an anti-C5a complementary peptide following acetylation of N-terminal alanine.
Okada N; Asai S; Hotta A; Miura N; Ohno N; Farkas I; Hau L; Okada H
Microbiol Immunol; 2007; 51(4):439-43. PubMed ID: 17446684
[TBL] [Abstract][Full Text] [Related]
9. Expression of an epitope tagged human C5a receptor and antibody-mediated immobilization of detergent-solubilized receptor for drug discovery screening.
Sloan DD; Barrett RW; Tate EH; England BP
Protein Expr Purif; 1997 Oct; 11(1):119-24. PubMed ID: 9325147
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 as a cytokine and therapeutic target.
Yang H; Wang H; Czura CJ; Tracey KJ
J Endotoxin Res; 2002; 8(6):469-72. PubMed ID: 12697092
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 as a DNA-binding cytokine.
Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
[TBL] [Abstract][Full Text] [Related]
12. Novel TLR4-antagonizing peptides inhibit LPS-induced release of inflammatory mediators by monocytes.
Yang QW; Mou L; Lv FL; Zhu PF; Wang ZG; Jiang JX; Wang JZ
Biochem Biophys Res Commun; 2005 Apr; 329(3):846-54. PubMed ID: 15752733
[TBL] [Abstract][Full Text] [Related]
13. Novel strategies for the treatment of sepsis.
Riedemann NC; Guo RF; Ward PA
Nat Med; 2003 May; 9(5):517-24. PubMed ID: 12724763
[TBL] [Abstract][Full Text] [Related]
14. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
Pavlov VA; Ochani M; Yang LH; Gallowitsch-Puerta M; Ochani K; Lin X; Levi J; Parrish WR; Rosas-Ballina M; Czura CJ; Larosa GJ; Miller EJ; Tracey KJ; Al-Abed Y
Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.
Finch AM; Wong AK; Paczkowski NJ; Wadi SK; Craik DJ; Fairlie DP; Taylor SM
J Med Chem; 1999 Jun; 42(11):1965-74. PubMed ID: 10354404
[TBL] [Abstract][Full Text] [Related]
16. Weak response of porcine C5a receptor towards human C5a in miniature pig endothelial cells and PMNs.
Yi KS; Lee S; Kang YH; Bae YS; Hwang SY; Ha I; Kim H; Kim MS; Cho B; Kang HJ; Bang KT; Kim JY; Yang J; Chung J; Ahn C
Xenotransplantation; 2007 Nov; 14(6):563-71. PubMed ID: 17991144
[TBL] [Abstract][Full Text] [Related]
17. Biologic activity of synthetic analogues of C5a anaphylatoxin.
Ember JA; Sanderson SD; Taylor SM; Kawahara M; Hugli TE
J Immunol; 1992 May; 148(10):3165-73. PubMed ID: 1578141
[TBL] [Abstract][Full Text] [Related]
18. C5a receptor antagonists for the treatment of inflammation.
Sumichika H
Curr Opin Investig Drugs; 2004 May; 5(5):505-10. PubMed ID: 15202723
[TBL] [Abstract][Full Text] [Related]
19. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
Lutz W; Stetkiewicz J
Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
[TBL] [Abstract][Full Text] [Related]
20. Anaphylatoxin C5a-induced toll-like receptor 4 signaling in bovine neutrophils.
Stevens MG; Van Poucke M; Peelman LJ; Rainard P; De Spiegeleer B; Rogiers C; Van de Walle GR; Duchateau L; Burvenich C
J Dairy Sci; 2011 Jan; 94(1):152-64. PubMed ID: 21183027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
